Retinopathy of Prematurity (ROP) is a potentially serious eye condition that primarily affects premature infants. It occurs when the blood vessels in the retina, the light-sensitive tissue at the back of the eye, do not develop properly. ROP is more common in babies born before 31 weeks of gestation or with a birth weight less than 1500 grams.
During normal development, blood vessels grow from the center of the retina towards the edges. In ROP, however, these vessels may stop growing or grow abnormally, leading to the formation of scar tissue or abnormal blood vessels. This can potentially cause vision problems or even blindness if left untreated.
ROP is typically diagnosed through a comprehensive eye examination by an ophthalmologist. The severity of the condition is categorized into different stages, with more advanced stages requiring prompt medical intervention.
Treatment options for ROP depend on the severity and may include laser therapy or injections to stop abnormal blood vessel growth. In some cases, surgery may be necessary.
Regular follow-up visits with an eye specialist are crucial for monitoring the condition and ensuring appropriate treatment. Early detection and intervention greatly improve the chances of preserving vision in infants affected by ROP.